Tardive Dyskinesia

Share:

Related Topics

Involuntary muscle tics may be a consequence of long-term “antipsychotic” medication use. According to research or other evidence, the following self-care steps may be helpful.

Get some extra E
Reduce the severity of TD by taking 1,600 IU of vitamin E every day under a doctor's supervision
Discover lecithin
Improve symptoms by taking 25 grams of this nutritional supplement twice a day, providing 35 grams of phosphatidyl choline per day
Mix in manganese
Prevent onset by taking 15 mg of manganese a day, or help reverse the condition by taking up to 60 mg per day under a doctor’s supervision
Manage movement with melatonin
With the supervision of a knowledgeable doctor, take 10 mg of this natural hormone each night to help reduce abnormal movements

References

1. Adler LA, Peselow E, Rotrosen J, et al. Vitamin E treatment of tardive dyskinesia. Am J Psychiatry 1993;150:1405–7.

2. Hashim S, Sajjad A. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different amounts. Int Clin Psychopharmacol 1988;13:147–55.

3. Sajjad SHA. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses. Int Clin Psychopahrmacol 1998;13:147–55.

4. Elkashef AM, Ruskin PE, Bacher N, Barrett D. Vitamin E in the treatment of tardive dyskinesia. Am J Psychiatry 990;147:505–6.

5. Lohrr JB, Cadet JL, Lohr MA. Alpha-tocopherol in tardive dyskinesia. Lancet 1987;1:913–4.

6. Shriqui CL, Bradwejn J, Annable L, Jones BD. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study. Am J Psychiatry 1992;149:391–3.

7. Dorevitch A, Kalian M, Shlafman M, Lerner V. Treatment of long-term tardive dyskinesia with vitamin E. Biol Psychiatry 1997;41:114–6.

8. Egan MF, Hyde TH, Albers GW, et al. Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 1992;149:773–7.

9. Lohr JB, Caligiuri MP. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. J Clin Psychiatry 1996;57:167–73.

10. Davis KL, Hollister LE, Barchas JD, Berger PA. Choline in tardive dyskinesia and Huntington’s disease: preliminary results from a pilot study. Life Sci 1976;19:1507–15.

11. Gelenberg AJ, Doller-Wojcik JC, Growdon JH. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry 1979;136:772–6.

12. Growdon JH, Hirsch MJ, Wurtman RJ, Wiener W. Oral choline administration to patients with tardive dyskinesia. N Engl J Med 1977;297:524–7.

13. Nasrallah HA, Dunner FJ, Smith RE, et al. Variable clinical response to choline in tardive dyskinesia. Psychol Med 1984;14:697–700.

14. Anderson BG, Reker D, Ristich M, et al. Lecithin treatment of tardive dyskinesia—a progress report. Psychopharmacol Bull 1982;18:87–8.

15. Jackson IV, Nuttall EA, Perez-Cruet J. Treatment of tardive dyskinesia with lecithin. Am J Psychiatr 1979;136:1458–60.

16. Kunin RA. Manganese in dyskinesias. Am J Psychiatry 1976;133:105.

17. Norris JP, Sams RE. More on the use of manganese in dyskinesia. Am J Psychiatry 1997;134:1448.

18. Hoffer A. Tardive dyskinesia treated with manganese. Can Med Assoc J 1977;117:859.

19. Shamir E, Barak Y, Shalman I, et al. Melatonin treatment for tardive dyskinesia. A double-blind, placebo-controlled, crossover study. Arch Gen Psychiatry 2001;58:1049–52.

20. Richardson MA, Bevans ML, Weber JB, et al. Branched chain amino acids decrease tardive dyskinesia symptoms. Psychopharmacology 1999;143:358–64.

21. Casey DE, Denney D. Dimethylaminoethanol in tardive dyskinesia. N Engl J Med 1974;291:797 [letter].

22. Soares, KV, McGrath JJ. The treatment of tardive dyskinesia–a systematic review and meta-analysis. Schizophr Res 1999;39:1–16 [review].

23. Vaddadi KS. Essential fatty acids and neuroleptic drug-associated tardive dyskinesia: preliminary clinical observations. IRCS Med Sci 1984;12:678.

24. Vaddadi KS, Courtney P, Gilleard CJ, et al. A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatr Res 1989;27:313–23.

25. Kozell L, Sandyk R, Wagner GC, Fisher H. The effects of L-tryptophan on haloperidol-induced movement disorder in the rat. Life Sci 1987;41:1739-44.

26. Sandyk R, Bamford CR, Khan I, Fisher H. L-tryptophan in neuroleptic-induced tardive dyskinesia. Int J Neurosci 1988;42:127-30.

27. Sandyk R, Consroe PF, Iacono RP. L-tryptophan in drug-induced movement disorders with insomnia. N Engl J Med 1986;314:1257.

28. Sandyk R, Consroe PF, Iacono RP. L-tryptophan in drug-induced movement disorders with insomnia. N Engl J Med 1986;314:1257.

29. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5–8.

30. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

31. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5–8.

32. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

33. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5–8.

34. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

35. Tkacz C. A preventive measure for tardive dyskinesia. J Int Acad Prev Med 1984;8:(5)5–8.

36. Toll N. To the editor. J Orthomolec Psychiatry 1982;11:42.

More Weight Loss Supplements

More Bodybuilding Supplements

More Bath & Beauty...

More Herbal Supplements

More Pet Care

More Sexual Health

More Kids Vitamins

Tardive Dyskinesia

Related Topics